A Real-world Study of Denosumab For Reducing Refracture Risk after Percutaneous Vertebral Augmentation.

Zou J, Zhang Y, Niu J, Song D, Huang Z, Li Z, Liu T, Meng B, Shi Q, Zhu X, Yang H.

Open source

DOI
10.1111/os.14087
Published
2024-07-01
Container
Orthop Surg
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/os.14087,
  title = {A Real-world Study of Denosumab For Reducing Refracture Risk after Percutaneous Vertebral Augmentation.},
  author = {Zou J and  Zhang Y and  Niu J and  Song D and  Huang Z and  Li Z and  Liu T and  Meng B and  Shi Q and  Zhu X and  Yang H.},
  year = {2024},
  journal = {Orthop Surg},
  doi = {10.1111/os.14087},
  url = {https://doi.org/10.1111/os.14087}
}

RIS

TY  - JOUR
TI  - A Real-world Study of Denosumab For Reducing Refracture Risk after Percutaneous Vertebral Augmentation.
AU  - Zou J
AU  -  Zhang Y
AU  -  Niu J
AU  -  Song D
AU  -  Huang Z
AU  -  Li Z
AU  -  Liu T
AU  -  Meng B
AU  -  Shi Q
AU  -  Zhu X
AU  -  Yang H.
PY  - 2024
JO  - Orthop Surg
DO  - 10.1111/os.14087
UR  - https://doi.org/10.1111/os.14087
ER  -

APA

J, Z., Y, Z., J, N., D, S., Z, H., Z, L., T, L., B, M., Q, S., X, Z., & H., Y. (2024). A Real-world Study of Denosumab For Reducing Refracture Risk after Percutaneous Vertebral Augmentation.. Orthop Surg. https://doi.org/10.1111/os.14087

Source records